MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the successful ...
Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology.
The patient received trifluridine/tipiracil plus bevacizumab as third-line therapy; is currently on month 4 of treatment. ...
RASolute 304 is anticipated to enroll approximately 500 patients with PDAC harboring oncogenic RAS mutations who have undergone resection and completed perioperative chemotherapy. The trial will ...
The clinical and biological features proposed here in conjunction with ML can improve the interpretation of CRC mechanisms and predict patient ...
Speaking at a hospice in Tunbridge Wells, she said: "I don't want to cloud her memory of me as just poorly." Beth added: "I ...
Canadian biotech Oncolytics Biotech (Nasdaq: ONCY) has reported encouraging clinical and translational data for its oncolytic ...
The Dawson's Creek alum, 48, was diagnosed with stage 3 colorectal cancer in 2023 and has been selling off merchandise from ...
This research delves into the association between anti-diabetic medications and cancer, exploring mechanisms beyond just ...
In conversations about health and nutrition, dietary fats often take center stage . While some oils are unfairly criticized, ...
Turkey tail mushroom may have benefits for immune and gut health. It contains polysaccharides, which may help prevent viral infections like HPV.
Sportschosun on MSN
5% of the population, fighting cancer... Cancer research trend report of the Korean Cancer Society pu
On the 18th, the Korean Cancer Society (Chairman La Sun-young, Professor of Yonsei University) held a press conference at Lotte Hotel in Sogong-dong, Seoul to commemorate the publication of the 「Korea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results